EM Imaging appoints new chairman
September 10, 2015Manufacturing and Production, Research and Development EM Imaging, Optometry, ophthalmology
The board of Edinburgh Molecular Imaging Ltd (EM Imaging) is pleased to announce the appointment of John Jeans as non-executive …
Featured market report: Healthcare mobility solutions market by products and services, global forecast to 2020
September 10, 2015Manufacturing and Production, Medical Communications, Sales and Marketing apps, healthcare mobility, market report, mobile healthcare, smartphones
The global healthcare mobility solutions market is set to grow by as much as 30% to 2020, as the healthcare …
Lung cancer market to hit $10.9bn by 2021
September 10, 2015Sales and Marketing AZD9291, GBI Research, GlobalData, NSCLC, industry analysis, industry intelligence, industry reports, keytruda, market intelligence lung cancer, market reports, market trends, non small cell lung cancer, non-small cell lung cancer, opdivo, world conference on lung cancer
The global market value for non-small cell lung cancer treatment will rise from $6.9 billion in 2014 to $10.9 billion …
Mylan to relaunch $27.1bn hostile takeover of Perrigo
September 10, 2015Sales and Marketing Mylan Perrigo, acquisitions, hostile bid, mergers, takeover
Mylan is to make yet another hostile $27.1 billion bid for Irish over the counter drug manufacturer Perrigo on Monday, …
Gilead’s Truvada prevents HIV infections in high-risk men
September 10, 2015Research and Development Gilead, HIV, PrEP, Truvada, pre-exposure prophylaxis treatment, sexually transmitted infections
UK researchers say Truvada, Gilead’s HIV prevention treatment, should be added to the country’s ‘HIV prevention toolkit’, after a study …
GSK begins work on £100m India facility
September 9, 2015Manufacturing and Production GlaxoSmithKline, India, manufacturing
GSK has begun work on its new Rs. 1000 crore (£100m) pharmaceutical factory in Vemgal, southern India. When fully operational …
Pharma leaders urge UK Government not to cut spending
September 9, 2015Research and Development Autumn spending review, George Osborne, R&D, government, research, research and development, research funding
Representatives of more than 200 life sciences organisations have urged the UK government to protect the sector from spending cuts. …
Neurimmune kicks off late-stage Alzheimer’s study
September 9, 2015Research and Development Alzheimer's disease, Biogen, Neurimmune, aducanumab, neurology
Neurimmune and its development partner Biogen are beginning a Phase III study of the companies’ potential Alzheimer’s treatment aducanumab. The …
GSK suffers Breo late-stage trial blow
September 9, 2015Research and Development COPD, GSK, Revlar, asthma, breo, clinical trial, phase III
GSK has hit a setback in its plans to expand sales of its blockbuster asthma treatment Breo, after a major …
Mission Therapeutics appoints new chief medical officer
September 9, 2015Medical Communications, Research and Development Dr Michael Koslowski, Mission Therapeutics
Mission Therapeutics has announced the appointment of Dr Michael Koslowski as chief medical officer. Dr Koslowski brings over 15 years’ …
Yabao Pharmaceutical and UniSA embark on joint venture
September 9, 2015Research and Development Cancer, Yabao Pharmaceutical
Yabao Pharmaceutical and the University of South Australia (UniSA) have joined together in a collaboration to develop new treatments for …
Biocair International Ltd achieves AEO approval
September 8, 2015Medical Communications Biocair
We are pleased to announce that as of 8th September 2015 Biocair International Ltd is an Authorised Economic Operator (AEO). …
Sun Pharma strengthens opiates business
September 8, 2015Manufacturing and Production Australia, GSK, Sun Pharma, manufacturing and production, opiates
Sun Pharmaceutical Industries has strengthened its global opiates manufacturing business with the acquisition of two Australian manufacturing facilities from GlaxoSmithKline. …
New treatment option for ovarian cancer patients in Scotland
September 8, 2015Medical Communications, Research and Development, Sales and Marketing Roche, Scotland, avastin, ovarian cancer
The Scottish Medicines Consortium (SMC) has approved the use of Avastin in combination with paclitaxel chemotherapy as a treatment for women …
EMA launches project to boost early patient access to drugs
September 8, 2015Research and Development EMA, European Medicines Agency, MAPPs, adaptive pathways, drug development, market access
The EMA is launching an adaptive pathway project to bring new medicinal products to market in Europe. The ADAPT SMART …
Novo Nordisk expands in Denmark
September 8, 2015Manufacturing and Production, Research and Development Denmark, Novo Nordisk, haemophilia API
Novo Nordisk has announced that the company is investing 500 million Danish kroner (about £48.8 million) in a new 19,000 …
Novo joins forces with MIT innovating drug devices
September 8, 2015Manufacturing and Production, Research and Development Novo Nordisk
Novo Nordisk has initiated a research collaboration with the Langer Laboratory at the Massachusetts Institute of Technology for what is …
Wave appoints Mehwish Abdeali as senior programme executive
September 8, 2015Medical Communications Mehwish Abdeali, wave
Mehwish Abdeali has been appointed as senior programme executive at Wave, a specialist medical education company. Mehwish joins Wave from …
ABPI ‘deeply concerned’ by slow UK drugs uptake
September 7, 2015Sales and Marketing ABPI, PPRS, Pharmaceutical Price Regulation Scheme, drugs bill, market access, medicines bill
The UK pharma industry paid £209 million to underwrite the UK medicines bill in second quarter of 2015, according to …
NICE recommends Keytruda for advanced skin cancer
September 7, 2015Research and Development, Sales and Marketing Merck, NICE, keytruda, skin cancer
NICE has approved Merck’s Keytruda (pembrolizumab) as a treatment for advanced skin cancer in final draft guidance for the NHS. …
Latest content
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
